A detailed history of Arrowstreet Capital, Limited Partnership transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 276,731 shares of COLL stock, worth $8.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
276,731
Previous 72,737 280.45%
Holding current value
$8.07 Million
Previous $2.34 Million 356.53%
% of portfolio
0.01%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.4 - $39.07 $6.41 Million - $7.97 Million
203,994 Added 280.45%
276,731 $10.7 Million
Q2 2024

Aug 14, 2024

SELL
$31.36 - $39.99 $6.45 Million - $8.23 Million
-205,776 Reduced 73.88%
72,737 $2.34 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $40.91 $1.85 Million - $2.42 Million
59,165 Added 26.97%
278,513 $10.8 Million
Q4 2023

Feb 14, 2024

SELL
$21.16 - $30.8 $4.47 Million - $6.5 Million
-211,195 Reduced 49.05%
219,348 $6.75 Million
Q3 2023

Nov 14, 2023

BUY
$21.23 - $24.28 $1.24 Million - $1.42 Million
58,339 Added 15.67%
430,543 $9.62 Million
Q2 2023

Aug 14, 2023

BUY
$21.06 - $24.0 $1.25 Million - $1.42 Million
59,330 Added 18.96%
372,204 $8 Million
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $7.2 Million - $9.35 Million
312,874 New
312,874 $7.51 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.